Larry Ellison Bankrolling £118M AI Vaccine Research at Oxford University

A research group funded by tech billionaire Larry Ellison is set to invest £118 million ($169.6 million) in applying AI to vaccine research with the UK's Oxford University. Oxford Vaccine Group is leading the project to study the human immune system's response to serious bacterial infections and antibiotic resistance, targeting diseases including Streptococcus pneumoniae, Staphylococcus aureus, and E. coli. Led by Professor Sir Andrew Pollard, who ran the trials for COVID-19 vaccines, the project plans to employ so-called human challenge models – which expose human volunteers to bacteria under controlled conditions – then apply modern immunology and AI tools to...